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Abstract
Background: Pentoxifylline (PTX) has been shown to reduce hepatic injury after normothermic ischemia and reperfusion
(I-R) in rat liver. Aim: The aim of this study was to evaluate the effects of PTX on liver expression of tumor necrosis factor
alpha (TNFa) mRNA following normothermic liver I-R. Materials and methods: A segmental normothermic ischemia of the
liver was induced in male Lewis rats by occluding the blood vessels including the bile duct to the median and left lateral
lobes for 90 min. At the end of ischemia the nonischemic liver lobes were resected. Rats were divided into three
groups: group 1, control Ringer lactate administration; group 2, PTX treatment; group 3, sham-operated control rats. PTX
(50 mg/kg) was injected intravenously 30 min before and 60 min after induction of ischemia. Survival rates were compared
and the serum activities of TNFa, serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate
dehydrogenase (LDH) were measured. Histology of the liver was assessed 6 h after reperfusion. Liver TNFa mRNA was
assessed by PCR amplification at 0, 60, 120, and 210 min after reperfusion. Results: PTX treatment significantly increased 7
day survival (93.3%) compared with nontreated control rats (46.6%, pB0.007). The extent of liver necrosis and the release
of liver enzymes were significantly decreased after PTX treatment. Serum activities of TNFa were significantly decreased
and liver expression of TNFa mRNA was inhibited after PTX treatment. Conclusion: PTX protects the liver from ischemic
injury and inhibits liver expression of TNFa mRNA.
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Introduction
Normothermic ischemia-reperfusion (I-R) injury oc-
curs during liver surgery (resection and transplanta-
tion) as well as during trauma and hemorrhagic shock
[1]. Normothermic I-R is poorly tolerated and rapidly
leads to death of hepatocytes, followed by liver
dysfunction [1]. In normothermic I-R, the activation
of hepatic macrophages, the Kupffer cells (KCs), is
responsible for a release of various cytokines including
tumor necrosis factor alpha (TNFa) [2]. TNFa plays
an important role in the induction of hepatocyte and
sinusoidal cell injury [3,4]. Pentoxifylline (PTX) is a
methylxanthine phosphodiesterase inhibitor com-
monly used to treat peripheral vascular diseases [5].
PTX has been shown to improve survival rate after
normothermic liver I-R [68] and hepatocellular
function after hemorrhagic trauma and resuscitation
[9]. Blockage of TNFa release from KCs by PTX
prevents up-regulation of TNFa expression after
normothermic I-R [10]. This inhibition of TNFa
expression results in a significant decrease of liver
injury and improves animal survival. PTX seems to
antagonize the effects of TNFa by inhibiting the
intracellular phosphodiesterase, resulting in a subse-
quent accumulation of intracellular c-AMP [11,12].
The aim of this study was to evaluate the effects of
PTX on TNFa mRNA liver expression following
normothermic liver I-R.
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Materials and methods
Animal preparation and hepatic ischemia procedure
A total of 146 male Lewis rats (LEW RTI1), weig-
hing 250300 g, were purchased from the CNRS-
CNSEAL (Orle´ans La Source, France); in each
experiment there was B25 g difference between the
animals. The rats were housed individually in plex-
iglass cages and were allowed free access to food and
water before, during, and after the ischemia. The
animal rooms were windowless with a temperature of
22928C and lighting controls (light on at 07.00 h and
off at 21.00 h; 14 h light/10 h dark). All animal
experiments were conducted in accordance with local
institutional guidelines for the care and use of
laboratory animals. All experiments were started
between 8 and 11 a.m. Before the operation an
indwelling intravenous line (Biotrol, Paris, France)
was placed in the right external jugular vein, with the
catheter tip positioned in the suprahepatic vena cava
just above the level of the hepatic dome to obtain
immediate post-hepatic blood samples and to admin-
ister intravenous fluids; correct catheter position was
confirmed at laparotomy. A segmental normothermic
ischemia of the liver was induced as described
previously [13]. Briefly, the anterior abdominal wall
was shaved and prepped with povidone-iodine solu-
tion (Betadine, Astra Medica, Merignac, France).
The abdomen was entered through a midline incision
under ether anesthesia and ischemia was induced by
occluding the blood vessels including the bile duct to
the median and left lateral lobes with an atraumatic
vascular clamp. After 90 min of warm ischemia the
vascular clamp was released and the nonischemic
(right lateral and caudate) lobes were resected, leaving
only the ischemic anterior lobes. This procedure was
considered to render ischemia in 70% of liver tissue
[14] and to avoid splanchnic stasis [15]. The abdo-
men was closed in two layers with 2-0 silk and
intravenous lactated Ringer solution at a dose of
0.75 ml was administered to replace operative fluid
and blood losses. After the operation animals were
kept in individual cages. Mortality rate and survival
times were recorded every 6 h. Animals that were alive
7 days after the operation were considered permanent
survivors. Necropsy was performed in all animals to
ensure absence of surgically related complications.
PTX (Torental†, Hoechst, Paris, France) was
suspended in Ringer lactate solution to a concentra-
tion of 50 mg/kg (0.75 ml) as described previously in
other studies [8,16,17].
Experimental groups
For survival analysis, 35 rats were prepared as described
above and divided into three groups. In group 1
(control group, n15), animals were injected intrave-
nously via the dorsal penile vein with 0.75 ml Ringer
lactate solution 30 min before induction of ischemia
and 30 min before reperfusion and resection of non-
ischemic liver lobes. Animals in group 2 (n15), were
injected intravenously via the dorsal penile vein with
0.75 ml of PTX 30 min before induction of ischemia
and 30 min before reperfusion and resection of non-
ischemic liver lobes. Group 3 animals were sham-
operated control animals (n5), in which the hilum
of the median and left lateral liver lobes was isolated
without applying a vascular clamp and the right lateral
and caudate lobes were resected 90 min after the first
operation. They received an intravenous injection of
0.75 ml Ringer lactate solution via the dorsal penile vein
30 min before the incision of the abdominal wall and
30 min before resection of right lateral and caudate
lobes.
Measurement of liver enzymes
Another set of 23 animals was prepared in the same
manner as decribed above for measurement of liver
enzymes. In groups 1 and 2 (10 rats for each group), 6
h after the end of ischemia, blood samples for
measurement of serum aspartate aminotransferase
(AST), alanine aminotransferase (ALT), and lactate
dehydrogenase (LDH) were obtained via the indwel-
ling venous line and quantified using standard clinical
automated analysis. Blood sampling at identical times
was performed in three sham-operated control ani-
mals.
Liver histology
For the histological study a total of 35 rats were
subjected to 90 min of normothermic hepatic ischemia.
Liver tissue was taken 6 h after the end of ischemia from
groups 1 and 2 (10 rats in each group) and from 3 sham-
operated control rats. Specimens were fixed in 10%
formalin and stained with hematoxylin and eosin (4 mm
sections) for light microscopic examination. The de-
gree of damage to the liver was determined as percen-
tage of total area that exhibited hepatocellular necrosis.
To avoid potential error in statistical sampling, 15 fields
were randomly selected under microscopy from each of
3 sections prepared from a liver. The area of hepatic
necrosis was determined in each field and the average
value calculated from 45 fields was used. Congestion,
infiltration of polymorphonuclear cells (PMNs), hy-
perplasia of sinusoidal cells, and steatosis were evalu-
ated according to the following criteria: no evidence
(0), low intensity (1), mild intensity (2), or high
intensity (3). Tissue from a further set of 12 rats
(5 from group 1, 5 from group 2, and 2 from the
sham-operated control group), was examined with a
transmission electron microscope (TEM). At 6 h after
reperfusion, rats were re-anesthetized and the liver was
fixed in vivo. Briefly, after isotonic saline administration
by direct puncture to the left ventricle and drainage by
an incision in the right atrium, a perfusate of 2%
glutaraldehyde (buffered to pH 7.4) was administered.
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Liver was excised immediately after cardiac arrest and
cut into 1 mm3 pieces that were post-fixed by immer-
sion in 2% glutaraldehyde for 2 h, then in 1% osmic acid
for 1 h. Each sample was dehydrated in increasing
alcohol concentrations and embedded in epoxy resin.
Ultra-thin sections were obtained by means of an
Ultratom. The samples were contrasted in 0.2% uranyl
acetate and lead citrate solution and subsequently
checked in a Jeol 1200 TEM.
Blood sampling for TNFa
Blood sampling was done in an additional group of 30
animals, which did not undergo the sampling for liver
enzyme measurement. To study the kinetics of TNFa
serum production following normothermic liver I-R,
in seven rats from the control group 300 ml of blood
were sampled from the indwelling suprahepatic cathe-
ter immediately after clamp removal and every 30 min
up to 420 min of reperfusion. Blood sampling of
300 ml at identical times was performed in three sham-
operated control animals.
To study the effects of PTX on TNFa serum
production following normothermic liver I-R, a
further set of 20 animals (10 rats each from groups
1 and 2) was prepared as described above for the
hepatic ischemia procedure. Blood sampling (300 ml)
was performed immediately after clamp removal and
at 60, 270, and 360 min of reperfusion; these time
points corresponded to the peaks in the kinetics of
TNFa serum production in the control group.
Lost blood was replaced with 300 ml of lactated
Ringer solution. Plasma was separated from the
samples and stored at 208C until assayed.
TNFa assay
Serum activity of TNFa was evaluated by measuring
its cytotoxic effect on Wehi 164 (clone 13) cells (25
MDP). Fifty microliters of successive serial dilutions
was distributed in 96-well microliter plates (Falcon,
BD, Biosciences, Le Pont de Claix, France), then, 50
ml of cells (510103 cells/well) was added. Sample
treated with neutralizing anti-TNFa antibody (Gen-
zyme, Cergy Saint Christophe, France) was used as a
test control. A TNFa solution with known titer was
the reference for the sample titer evaluation. After
incubation for 810 h, the cytotoxic effect was
evaluated by optic microscopy and could be followed
by a spectrophotometric method using 3-(4,5-di-
methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT, Sigma-Aldrich, Saint Quentin Fallavier,
France). TNFa titer corresponded to the reciprocal
of the dilution factor that lysed 50% of the cells. Wehi
164 is an established cell line from murine fibrosar-
coma. Clone 13 is highly TNFa sensitive. Cells were
cultivated in RPMI 1640 culture medium enriched
with 510% SVF (Flow), 0.1 mM glutamine, and 30
mg/ml gentamicin. In this assay, the lower limit of
detectable TNFa was 10 pg/ml.
Reverse transcription-polymerase chain reaction
(RT-PCR) analysis for TNFa
To study the kinetics of TNFa at the transcription
level, liver tissue was taken from 23 rats as follows: 0
(immediately after clamp removal), 60, 120, and 210
minutes after reperfusion. Total RNAs were isolated
from samples of frozen liver (1 g) using a guanidine
isothiocyanate-cesium chloride gradient procedure
[18]. Total RNAs (5 mg) were first reverse-tran-
scribed into cDNA using oligo (dT) 1218 as primer
and AMV reverse transcriptase (Boehringer, Man-
nheim, Germany). Reverse transcripts (equivalent to
125 ng of total RNA) were used directly for each
amplification reaction. Conditions for PCR were as
follows. In a 50 ml reaction, 25 nmol of each primer,
125 mM each of dGTP, dATP, dCTP, and dTTP,
50 mM KCl, 10 mM Tris-HCl, pH 8.3, 1.5 mM
MgCl2, 1 mg/ml gelatin, 100 mg/ml of nonacetylated
BSA, and 1 unit of TAQ DNA polymerase (Boeh-
ringer). Primer sequences were as follows. TNFa-
sense: 5?-CAG GGC AAT GAT CCC AAA GTA-3?
and TNFa-anti-sense 5?-GCA GTC AGA TCA
TCT TCT CGA-3?. Reactions were incubated in a
DNA thermal cycler for 35 cycles (denaturation
1 min at 948C, annealing 90 s at 568C, and exten-
sion 2 min at 728C). PCR amplification of a
constitutively expressed control mRNA encoding
actin (b actin-sense: 5?-GTG GGG CGC CCC
AGG CAC CA-3?, b actin-anti-sense: 5?-GTC
CTT AAT GTC ACG CAC GAT TTC-3’) was
used as a measure of the amount of input RNA. The
reaction mixture was extracted with CHCl3, sepa-
rated in a 1% agarose gel, and Southern blot analysis
was performed with a 1.13 kb HindIII-EcoRI frag-
ment from pTNFaAM5 plasmid as probe [19].
Probe was labelled with [a 32P]dCTP (Amersham,
Little Chalfont, UK) to high specific activity (108
cpm/mg) by the nonamer random primed labeling
technique (Megaprime kit, Amersham, Little Chal-
font, UK). Filter was washed under stringent condi-
tions (658C, in 0.1SSC/0.1% SDS) and exposed
to Hyperfilm MP (Amersham).
A 1.13 kb HindIII-EcoRI fragment from
pTNFaAM5 plasmid was used for the identification
of TNFa in the rat liver. TNFaAM5 plasmid, which
contains the cDNA of the murine TNFa [20],
was generously provided by Dr J. Doly (Villejuif,
France).
Statistical analysis
Results were expressed as mean9SEM. The propor-
tions of surviving rats in the groups were compared
using Fisher’s exact test. The comparison for statis-
tical significance was performed according to the
114 A. El-Ghoneimi et al.
Student-Newmann-Keuls test for serum activities of
aminotransferases, LDH, TNFa, and histological
parameters. Statistical significance was set at pB
0.05. Error bars in figures represent standard errors.
Results
Survival rate
The 7 day survival of animals is illustrated in Figure 1.
Treatment with PTX significantly improved the
survival rate following 90 min normothermic liver
ischemia (93.3%), compared with the control group
(46.6%, pB0.007). In the control group seven rats
died within 18 h of surgery, whereas one rat died in
the PTX-treated group. Autopsy of the rats showed
severe necrosis of the liver in all cases. In sham-
operated control rats the 7 day survival was 100%.
AST, ALT, and LDH serum levels
In groups 1 and 2, serum AST, ALT, and LDH
levels were increased 6 h after the end of ischemia
(Figure 2A and B). However, the release of liver
enzymes was significantly lower in animals treated
with PTX (AST, 440592519 UI/L; ALT, 34189
2874 UI/L; LDH, 32802927768 UI/L) compared
with those of the control group (AST, 74769213 UI/
L; ALT, 65019304 UI/L; LDH, 741739169 UI/L)
(AST, pB0.008; ALT, pB0.03; LDH, pB0.001). In
sham-operated control animals, serum AST, ALT,
and LDH were 250924 UI/L, 295979 UI/L, and
590955 UI/L, respectively.
Macroscopic appearance and histology
Immediately after occlusion of the hepatic vessels,
the anterior lobes became pale. After releasing the
clamp, the liver turned dark and rapidly regained
its normal color. At 6 h after reperfusion the severity
Figure 1. Effect of pentoxifylline (PTX) on the 7 day survival
following normothermic liver I-R. Control group, n15; PTX
group, n15; h, hours; d, days.
Figure 2. (A) Effect of pentoxifylline (PTX) on ASTand ALT serum levels 6 h after normothermic liver I-R. Group control (n10), group
PTX (n10), and group sham-operated rats (n3). Values are mean9SEM. Error bars represent standard errors. *pB0.008, **pB0.03.
(B) Effect of PTX on LDH serum levels 6 h after normothermic liver I-R. Control group (n10), PTX group (n10), and sham-operated
group (n3). Values are mean9SEM. Error bars represent standard errors. *pB0.001.
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of liver necrosis was more evident in the control
group (Figure 3A) than in the PTX-treated group
(Figure 3B). As shown in Figure 3C, the percentage
of necrotic area 6 h after reperfusion was signifi-
cantly lower in the PTX-treated group than in the
control group (31.1911 vs 41.096.4, pB0.02).
The localization of necrosis was heterogeneous,
predominating in subcapsular and mediolobular
areas and centered around the central vein. No
significant difference was observed between groups
1 and 2 with respect to congestion (2.990.3 vs 2.89
0.6, p0.05), infiltration of PMNs (1.690.9 vs
1.190.8, p0.05), hyperplasia of sinusoidal cells
(1.491.0 vs 1.290.9, p0.05), and steatosis (0.69
0.6 vs 0.590.7, p0.05). In the sham-operated
control animals, necrotic area was B5%.
At 6 h after reperfusion, TEM showed no signifi-
cant difference between groups 1 and 2. Lesions were
observed particularly near to the necrotic regions
(results not shown). These lesions involved the
hepatocytes (mitochondria and endoplasmic reticu-
lum dilation, destruction of microvilli, vacuolization),
the Disse space (destruction of basal membrane and
accumulation of heterogeneous microfibrillar materi-
als), and endothelial cells (accumulation of intracyto-
plasmic vacuoles and rupture of basal membrane).
Kupffer cells showed various degrees of activation. No
ultrastructural lesions were observed in sham-oper-
ated control animals.
TNFa serum levels following liver I-R
After 90 min normothermic liver I-R, TNFa was
detectable in the blood of animals of the control group
between 30 and 420 min of reperfusion (Figure 4),
whereas it remained undetectable at any time point in
sham-operated control animals (results not shown).
The time point at which the TNFa serum level
peaked was variable, occurring between 270 and
420 min after reperfusion. The mean peak of TNFa
level was 90.7957.4 pg/ml with a range of 5160 pg/
ml. As shown in Figure 5, treatment with PTX
significantly decreased the TNFa serum levels 270
min (31.295.6 pg/ml in group 2 vs 103.597.3 pg/ml
in group 1, pB0.001) and 360 min (19.593.2 in
group 2 vs 66.594.8 pg/ml in group 1, pB0.02) after
reperfusion. There was no significant difference
between the groups 60 min after reperfusion (29.09
4.7 pg/ml in group 2 vs 38.792.9 pg/ml in group 1,
p0.59). In both groups, TNFa was undetectable
in samples obtained immediately after clamp removal
(0 min after reperfusion).
Figure 3. Effect of pentoxifylline (PTX) on liver necrosis following
normothermic liver I-R. Representative hematoxylin and eosin
images of liver sections 6 h after reperfusion (original
magnification100) from control group (A) and PTX-treated
group (B). Quantitative analysis of liver necrosis (C). Ten animals
per group were studied at each time interval. Values are mean9
SEM. Error bars represent standard errors. *pB0.02.
Figure 4. Kinetic of TNFa serum production following normother-
mic liver I-R. Seven animals were studied at each time interval.
Values are mean9SEM. Error bars represent standard errors.
116 A. El-Ghoneimi et al.
Detection of liver TNFa mRNA by PCR amplification
TNFa mRNA was not detectable by Northern blot
analysis. Therefore, TNFa mRNA was estimated by
PCR amplification from liver tissue harvested at
different times after reperfusion. In the control
group, TNFa transcript was detected at 60 and
210 min after reperfusion, but was not detectable at
the intermediate time of 120 min after reperfusion
(Figure 6A). In contrast, at each time interval
studied, TNFa mRNA was not detected in the liver
of PTX-treated animals (Figure 6B).
Discussion
This study showed that PTX treatment improves
survival after normothermic liver I-R, and leads to a
reduction of liver injury, a decrease in aminotrans-
ferases, LDH, and TNFa serum levels, and an
inhibition of the TNFa mRNA liver expression.
There are two distinct phases of liver reperfusion
injury, the early phase (up to 2 h post reperfusion) and
the late phase (424 h) [2]. The early phase is
characterized mainly by activation of complement
and KCs and the production of free radicals. Activa-
tion of KCs during reperfusion results in a massive
release of cytokines such as TNFa [2]. The main
event during the late phase is the accumulation of
activated neutrophils and the production of free
radicals and proteases [2].
TNFa is responsible for lung and hepatic injury and
leukocyte infiltration after hepatic I-R in rats [4].
Treatment with anti-TNFa antibodies has reduced
pulmonary and hepatic injury after normothermic
and cold hepatic ischemia [3,4]. It has been reported
that TNFa stimulates neutrophil adhesion to hepatic
sinusoidal endothelial cells in rats [21] and may
activate endothelial cells to initiate coagulation [22].
In this study, in the control group, 90 min lobar
normothermic liver ischemia followed by reperfusion
and 30% hepatectomy (involving the nonischemic
Figure 5. Effect of pentoxifylline (PTX) on TNFa serum levels
during normothermic liver I-R. Ten animals per group were studied
at each time interval. Values are mean9SEM. Error bars represent
standard errors. *pB0.001, **pB0.02.
Figure 6. (A) Liver expression of TNFa mRNA following normothermic liver I-R. A total of 14 rats were studied, each number below the
figure corresponds to one rat. Data are expressed as means9SEM of a representative experiment out of three comparable ones, each
performed in triplicate. (B) Effects of pentoxifylline (PTX) on liver expression of TNFa mRNA following normothermic liver I-R. A total of
nine rats were studied, each number below the figure corresponds to one rat. Data are expressed as means9SEM of a representative
experiment out of three comparable ones, each performed in triplicate.
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lobes) resulted in post-hepatic (suprahepatic vena
cava) blood release of TNFa. This effect is in line
with a previous study [13]. PTX treatment decreased
TNFa serum levels at each time interval studied.
These findings are consistent with reports from other
investigators [6,7].
Previous studies have reported that PTX improves
the portal circulation and reduces the intrahepatic
vascular resistance [23], reducing leukocyteendothe-
lial adherence [24,25]. PTX has an inhibitory effect
on the production of cell mediators like superoxide
anions [26], IL-2 [25], and TNFa [26].
In this study, in the control group, PCR amplifica-
tion assay showed TNFa mRNA liver expression at 60
and 210 min after I-R. This biphasic kinetic corre-
sponded to the time necessary for protein translation.
TNFa mRNA liver expression at 60 and 210 min after
I-R was inhibited by PTX treatment. This inhibitory
effect in vivo of PTX on TNFa mRNA liver expres-
sion after normothermic liver I-R confirms the results
of a previous study in vitro [11].
Because of its inhibitory effect on TNFa mRNA
liver expression at 60 and 210 min after I-R, it can
also be assumed that PTX treatment was responsible
for the decrease of TNFa serum levels at 270 and 360
min after I-R. Nevertheless, the inhibition of TNFa
mRNA liver expression by PTX as the protective
mechanism of liver I-R injury remains only associative
in the present study.
In conclusion, our study showed that PTX treat-
ment improves survival, reduces liver injury, and
decreases TNFa serum levels with inhibition of
TNFa mRNA liver expression in the liver after
normothermic I-R.
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